A Novel Therapeutic Target for Mitochondrial Dysfunction

Mitochondrial dysfunction is a major contributor to a wide range of complex diseases. This deficiency in mitochondrial function can lead to cellular failure, ultimately resulting in various pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising treatment for addressing this debilitating issue. check here EPT Fumarate acts

read more